{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:17:56Z","timestamp":1792905476658,"version":"4.5.0"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To provide evidence-based recommendations on the management of malignant bowel obstruction (MBO) for patients with advanced cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Multinational Association for Supportive Care in Cancer (MASCC) MBO study group conducted a systematic review of databases (inception to March 2021) to identify studies about patients with advanced cancer and MBO that reported on the following outcomes: symptom management, bowel obstruction resolution, prognosis, overall survival, and quality of life. The review was restricted to studies published in English, but no restrictions were placed on publication year, country, and study type. As per the MASCC Guidelines Policy, the findings were synthesized to determine the levels of evidence to support each MBO intervention and, ultimately, the graded recommendations and suggestions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The systematic review identified 17,656 published studies and 397 selected for the guidelines. The MASCC study group developed a total of 25 evidence-based suggestions and recommendations about the management of MBO-related nausea and vomiting, bowel movements, pain, inflammation, bowel decompression, and nutrition. Expert consensus-based guidance about advanced care planning and psychosocial support is also provided.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This MASCC Guideline provides comprehensive, evidence-based recommendations about MBO management for patients with advanced cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-022-06889-8","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T18:02:16Z","timestamp":1646935336000},"page":"4711-4728","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer"],"prefix":"10.1007","volume":"30","author":[{"given":"Ainhoa","family":"Madariaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunangshu","family":"Ghoshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Dzier\u017canowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Sobocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Dickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Furness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouhi","family":"Fazelzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory B","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lheureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"6889_CR1","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.jpainsymman.2007.04.011","volume":"34","author":"T Anthony","year":"2007","unstructured":"Anthony T, Baron T, Mercadante S et al (2007) Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction. J Pain Symptom Manage 34:S49-59","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR2","doi-asserted-by":"publisher","unstructured":"Cousins SE, Tempest E, Feuer DJ (2016) Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev\u00a02016(1):CD002764. https:\/\/doi.org\/10.1002\/14651858.CD002764.pub2","DOI":"10.1002\/14651858.CD002764.pub2"},{"key":"6889_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.ejca.2008.02.028","volume":"44","author":"CI Ripamonti","year":"2008","unstructured":"Ripamonti CI, Easson AM, Gerdes H (2008) Management of malignant bowel obstruction. Eur J Cancer 44:1105\u201315","journal-title":"Eur J Cancer"},{"key":"6889_CR4","doi-asserted-by":"publisher","first-page":"1867238","DOI":"10.1155\/2018\/1867238","volume":"2018","author":"YC Lee","year":"2018","unstructured":"Lee YC, Jivraj N, O\u2019Brien C et al (2018) Malignant bowel obstruction in advanced gynecologic cancers: an updated review from a multidisciplinary perspective. Obstet Gynecol Int 2018:1867238","journal-title":"Obstet Gynecol Int"},{"key":"6889_CR5","doi-asserted-by":"publisher","unstructured":"National Audit of Small Bowel Obstruction Steering Group & National Audit of Small Bowel Obstruction Collaborators (2019) Outcomes following small bowel obstruction due to malignancy in the national audit of small bowel obstruction. Eur J Surg Oncol 45(12):2319\u20132324.\u00a0https:\/\/doi.org\/10.1016\/j.ejso.2019.07.014","DOI":"10.1016\/j.ejso.2019.07.014"},{"key":"6889_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/01635581.2020.1767165","volume":"73","author":"PS Patel","year":"2021","unstructured":"Patel PS, Fragkos KC, Keane N et al (2021) Clinical and nutritional care pathways of patients with malignant bowel obstruction: a retrospective analysis in a tertiary UK center. Nutr Cancer 73:572\u2013587","journal-title":"Nutr Cancer"},{"key":"6889_CR7","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/01635581.2016.1159702","volume":"68","author":"GW Yim","year":"2016","unstructured":"Yim GW, Eoh KJ, Kim SW et al (2016) Malnutrition identified by the nutritional risk index and poor prognosis in advanced epithelial ovarian carcinoma. Nutr Cancer 68:772\u20139","journal-title":"Nutr Cancer"},{"key":"6889_CR8","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.clnu.2018.04.007","volume":"38","author":"KM Marshall","year":"2019","unstructured":"Marshall KM, Loeliger J, Nolte L et al (2019) Prevalence of malnutrition and impact on clinical outcomes in cancer services: a comparison of two time points. Clin Nutr 38:644\u2013651","journal-title":"Clin Nutr"},{"key":"6889_CR9","doi-asserted-by":"publisher","first-page":"S305","DOI":"10.1016\/j.jacr.2020.01.025","volume":"17","author":"KJ Chang","year":"2020","unstructured":"Chang KJ, Marin D, Kim DH et al (2020) ACR appropriateness criteria\u00ae Suspected small-bowel obstruction. J Am Coll Radiol 17:S305-s314","journal-title":"J Am Coll Radiol"},{"key":"6889_CR10","doi-asserted-by":"publisher","unstructured":"Puchalski CM, Sbrana A, Ferrell B, et al. (2019) Interprofessional spiritual care in oncology: a literature review. ESMO Open\u00a04(1):e000465.\u00a0https:\/\/doi.org\/10.1136\/esmoopen-2018-000465","DOI":"10.1136\/esmoopen-2018-000465"},{"key":"6889_CR11","doi-asserted-by":"publisher","unstructured":"Crawford GB, Dzier\u017canowski T, Hauser K, et al. (2021) Care of the adult cancer patient at the end of life: ESMO clinical practice guidelines. ESMO Open 6(4):100225. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100225","DOI":"10.1016\/j.esmoop.2021.100225"},{"key":"6889_CR12","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1002\/cncr.29602","volume":"121","author":"D Hui","year":"2015","unstructured":"Hui D, Hess K, dos Santos R et al (2015) A diagnostic model for impending death in cancer patients: preliminary report. Cancer 121:3914\u201321","journal-title":"Cancer"},{"key":"6889_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2017.06.002","volume":"116","author":"RD Dolan","year":"2017","unstructured":"Dolan RD, McSorley ST, Horgan PG et al (2017) The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol 116:134\u2013146","journal-title":"Crit Rev Oncol Hematol"},{"key":"6889_CR14","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jpainsymman.2016.12.330","volume":"53","author":"CPL Simmons","year":"2017","unstructured":"Simmons CPL, McMillan DC, McWilliams K et al (2017) Prognostic tools in patients with advanced cancer: a systematic review. J Pain Symptom Manage 53:962-970.e10","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR15","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1200\/JCO.2017.75.2311","volume":"35","author":"T Gilligan","year":"2017","unstructured":"Gilligan T, Coyle N, Frankel RM et al (2017) Patient-clinician communication: American Society of Clinical Oncology consensus guideline. J Clin Oncol 35:3618\u20133632","journal-title":"J Clin Oncol"},{"key":"6889_CR16","doi-asserted-by":"publisher","unstructured":"Davis M, Hui D, Davies A, et al. (2021) Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update. Support Care Cancer 29(12):8089\u20138096. https:\/\/doi.org\/10.1007\/s00520-021-06438-9","DOI":"10.1007\/s00520-021-06438-9"},{"key":"6889_CR17","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jpainsymman.2016.05.032","volume":"52","author":"GP Obita","year":"2016","unstructured":"Obita GP, Boland EG, Currow DC et al (2016) Somatostatin analogues compared with placebo and other pharmacologic agents in the management of symptoms of inoperable malignant bowel obstruction: a systematic review. J Pain Symptom Manage 52:901-919.e1","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s005200050283","volume":"8","author":"S Mercadante","year":"2000","unstructured":"Mercadante S, Ripamonti C, Casuccio A et al (2000) Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 8:188\u201391","journal-title":"Support Care Cancer"},{"key":"6889_CR19","doi-asserted-by":"publisher","unstructured":"Peng X, Wang P, Li S, et al. (2015) Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer. World J Surg Oncol\u00a013:50. https:\/\/doi.org\/10.1186\/s12957-015-0455-3","DOI":"10.1186\/s12957-015-0455-3"},{"key":"6889_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0885-3924(99)00147-5","volume":"19","author":"C Ripamonti","year":"2000","unstructured":"Ripamonti C, Mercadante S, Groff L et al (2000) Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage 19:23\u201334","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR21","first-page":"1187","volume":"22","author":"K Mystakidou","year":"2002","unstructured":"Mystakidou K, Tsilika E, Kalaidopoulou O et al (2002) Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial. Anticancer Res 22:1187\u201392","journal-title":"Anticancer Res"},{"key":"6889_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/0885-3924(91)90005-O","volume":"6","author":"F De Conno","year":"1991","unstructured":"De Conno F, Caraceni A, Zecca E et al (1991) Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage 6:484\u20136","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/1049909108327967","volume":"26","author":"C Weber","year":"2009","unstructured":"Weber C, Zulian GB (2009) Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics. Am J Hosp Palliat Care 26:84\u20138","journal-title":"Am J Hosp Palliat Care"},{"key":"6889_CR24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0885-3924(98)00101-8","volume":"16","author":"S Mercadante","year":"1998","unstructured":"Mercadante S (1998) Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction. J Pain Symptom Manage 16:278\u201380","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0885-3924(99)00063-9","volume":"18","author":"MP Davis","year":"1999","unstructured":"Davis MP, Furste A (1999) Glycopyrrolate: a useful drug in the palliation of mechanical bowel obstruction. J Pain Symptom Manage 18:153\u20134","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR26","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S0140-6736(85)90534-3","volume":"2","author":"M Baines","year":"1985","unstructured":"Baines M, Oliver DJ, Carter RL (1985) Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study. Lancet 2:990\u20133","journal-title":"Lancet"},{"key":"6889_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0885-3924(94)90141-4","volume":"9","author":"RL Fainsinger","year":"1994","unstructured":"Fainsinger RL, Spachynski K, Hanson J et al (1994) Symptom control in terminally ill patients with malignant bowel obstruction (MBO). J Pain Symptom Manage 9:12\u20138","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1089\/109662101753124048","volume":"4","author":"JC Muir","year":"2001","unstructured":"Muir JC, von Gunten CF (2001) Abdominal cancer, nausea, and vomiting. J Palliat Med 4:391\u20134","journal-title":"J Palliat Med"},{"key":"6889_CR29","unstructured":"Lexi-drugs online [database on the Internet]. Hudson (OH): Lexicomp, Inc.; 2021 [updated 23 Sept 2021; cited 26 Sept 2021]. Available from: http:\/\/online.lexi.com. Subscription required to view. Accessed 1 July 2021"},{"key":"6889_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/1049909115569047","volume":"33","author":"J Berger","year":"2016","unstructured":"Berger J, Lester P, Rodrigues L (2016) Medical therapy of malignant bowel obstruction with octreotide, dexamethasone, and metoclopramide. Am J Hosp Palliat Care 33:407\u201310","journal-title":"Am J Hosp Palliat Care"},{"key":"6889_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jpainsymman.2004.01.007","volume":"28","author":"S Mercadante","year":"2004","unstructured":"Mercadante S, Ferrera P, Villari P et al (2004) Aggressive pharmacological treatment for reversing malignant bowel obstruction. J Pain Symptom Manage 28:412\u20136","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jpainsymman.2008.01.014","volume":"37","author":"A Tuca","year":"2009","unstructured":"Tuca A, Roca R, Sala C et al (2009) Efficacy of granisetron in the antiemetic control of nonsurgical intestinal obstruction in advanced cancer: a phase II clinical trial. J Pain Symptom Manage 37:259\u201370","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0885-3924(01)00376-1","volume":"23","author":"C Clare","year":"2002","unstructured":"Clare C, Bennett M (2002) Tolerance issues in the use of somatostatin analogs in palliative care [1]. J Pain Symptom Manag 23:87\u201388","journal-title":"J Pain Symptom Manag"},{"key":"6889_CR34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jpainsymman.2014.09.013","volume":"49","author":"DC Currow","year":"2015","unstructured":"Currow DC, Quinn S, Agar M et al (2015) Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. J Pain Symptom Manage 49:814\u201321","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jpainsymman.2005.05.018","volume":"30","author":"UA Matulonis","year":"2005","unstructured":"Matulonis UA, Seiden MV, Roche M et al (2005) Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer. J Pain Symptom Manage 30:563\u20139","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR36","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1684\/bdc.2011.1535","volume":"99","author":"G Laval","year":"2012","unstructured":"Laval G, Rousselot H, Toussaint-Martel S et al (2012) SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction. Bull Cancer 99:E1\u2013E9","journal-title":"Bull Cancer"},{"key":"6889_CR37","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1200\/JCO.2011.40.5712","volume":"30","author":"P Mariani","year":"2012","unstructured":"Mariani P, Blumberg J, Landau A et al (2012) Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol 30:4337\u20134343","journal-title":"J Clin Oncol"},{"key":"6889_CR38","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1186\/s12885-020-07549-y","volume":"20","author":"N McCaffrey","year":"2020","unstructured":"McCaffrey N, Asser T, Fazekas B et al (2020) Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide. BMC Cancer 20:1050","journal-title":"BMC Cancer"},{"key":"6889_CR39","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jpainsymman.2011.10.023","volume":"44","author":"K Kaneishi","year":"2012","unstructured":"Kaneishi K, Kawabata M, Morita T (2012) Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction. J Pain Symptom Manage 44:604\u20137","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR40","unstructured":"Bashir A, Sizar O. Laxatives. [Updated 2021 Sep 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537246\/ Accessed on: 20th July, 2021."},{"key":"6889_CR41","doi-asserted-by":"crossref","unstructured":"Larkin PJ, Cherny NI, La Carpia D, et al. (2018) Diagnosis, assessment and management of constipation in advanced cancer: ESMO clinical practice guidelines. Ann Oncol 29:iv111\u2013iv125","DOI":"10.1093\/annonc\/mdy148"},{"key":"6889_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/CMAR.S29297","volume":"4","author":"A Tuca","year":"2012","unstructured":"Tuca A, Guell E, Martinez-Losada E et al (2012) Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution. Cancer Manag Res 4:159\u201369","journal-title":"Cancer Manag Res"},{"key":"6889_CR43","unstructured":"WHO (2019) Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. https:\/\/www.who.int\/publications\/i\/item\/9789241550390 Accessed on: 1st June 2021."},{"key":"6889_CR44","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1177\/0269216310383739","volume":"25","author":"L Radbruch","year":"2011","unstructured":"Radbruch L, Trottenberg P, Elsner F et al (2011) Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: an EPCRC opioid guidelines project. Palliat Med 25:578\u201396","journal-title":"Palliat Med"},{"key":"6889_CR45","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-2036.2009.04212.x","volume":"31","author":"RE Kraichely","year":"2010","unstructured":"Kraichely RE, Arora AS, Murray JA (2010) Opiate-induced oesophageal dysmotility. Aliment Pharmacol Ther 31:601\u20136","journal-title":"Aliment Pharmacol Ther"},{"key":"6889_CR46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.12788\/jhm.3187","volume":"14","author":"K Hsu","year":"2019","unstructured":"Hsu K, Prommer E, Murphy MC et al (2019) Pharmacologic management of malignant bowel obstruction: when surgery is not an option. J Hosp Med 14:367\u2013373","journal-title":"J Hosp Med"},{"key":"6889_CR47","unstructured":"TABLETS DECADRON\u00ae (DEXAMETHASONE TABLETS, USP). U.S. Food and Drug Administration website. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/11664slr062_decadron_lbl.pdf Accessed on 15th August 2021."},{"key":"6889_CR48","doi-asserted-by":"crossref","unstructured":"Feuer DJ, Broadley KE (2000) Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev 2000:Cd001219","DOI":"10.1002\/14651858.CD002764"},{"key":"6889_CR49","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jpainsymman.2005.10.009","volume":"31","author":"G Laval","year":"2006","unstructured":"Laval G, Arvieux C, Stefani L et al (2006) Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Center. J Pain Symptom Manage 31:502\u201312","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1006\/gyno.1999.5406","volume":"74","author":"J Philip","year":"1999","unstructured":"Philip J, Lickiss N, Grant PT et al (1999) Corticosteroids in the management of bowel obstruction on a gynecological oncology unit. Gynecol Oncol 74:68\u201373","journal-title":"Gynecol Oncol"},{"key":"6889_CR51","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jpainsymman.2017.10.019","volume":"55","author":"T Minoura","year":"2018","unstructured":"Minoura T, Takeuchi M, Morita T et al (2018) Practice patterns of medications for patients with malignant bowel obstruction using a nationwide claims database and the association between treatment outcomes and concomitant use of h<sub>2<\/sub>-blockers\/proton pump inhibitors and corticosteroids with. J Pain Symptom Manage 55:413-419.e2","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR52","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1191\/026921698666334766","volume":"12","author":"J Hardy","year":"1998","unstructured":"Hardy J, Ling J, Mansi J et al (1998) Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliat Med 12:437\u201342","journal-title":"Palliat Med"},{"key":"6889_CR53","doi-asserted-by":"publisher","unstructured":"Syrmis W, Richard R, Jenkins-Marsh S, et al. (2018) Oral water soluble contrast for malignant bowel obstruction. Cochrane Database Syst Rev\u00a03(3):CD012014. https:\/\/doi.org\/10.1002\/14651858.CD012014.pub2","DOI":"10.1002\/14651858.CD012014.pub2"},{"key":"6889_CR54","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/1049909112471422","volume":"30","author":"C Lee","year":"2013","unstructured":"Lee C, Vather R, O\u2019Callaghan A et al (2013) Validation of the phase II feasibility study in a palliative care setting: gastrografin in malignant bowel obstruction. Am J Hosp Palliat Care 30:752\u20138","journal-title":"Am J Hosp Palliat Care"},{"key":"6889_CR55","doi-asserted-by":"crossref","unstructured":"Khasawneh MA, Eiken PW, Srvantstyan B, et al. (2013) Use of the Gastrografin challenge in patients with a history of abdominal or pelvic malignancy. Surgery 154:769\u201375 discussion 775","DOI":"10.1016\/j.surg.2013.07.002"},{"key":"6889_CR56","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/1049909111406706","volume":"28","author":"EA Dolan","year":"2011","unstructured":"Dolan EA (2011) Malignant bowel obstruction: a review of current treatment strategies. Am J Hosp Palliat Care 28:576\u201382","journal-title":"Am J Hosp Palliat Care"},{"key":"6889_CR57","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpainsymman.2013.08.022","volume":"48","author":"G Laval","year":"2014","unstructured":"Laval G, Marcelin-Benazech B, Guirimand F et al (2014) Recommendations for bowel obstruction with peritoneal carcinomatosis. J Pain Symptom Manag 48:75\u201391","journal-title":"J Pain Symptom Manag"},{"key":"6889_CR58","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s005200000198","volume":"9","author":"C Ripamonti","year":"2001","unstructured":"Ripamonti C, Twycross R, Baines M et al (2001) Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 9:223\u201333","journal-title":"Support Care Cancer"},{"key":"6889_CR59","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/145749691210100302","volume":"101","author":"S Prabhakaran","year":"2012","unstructured":"Prabhakaran S, Doraiswamy VA, Nagaraja V et al (2012) Nasoenteric tube complications. Scand J Surg 101:147\u201355","journal-title":"Scand J Surg"},{"key":"6889_CR60","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/00006250-198609000-00030","volume":"68","author":"JM Malone Jr","year":"1986","unstructured":"Malone JM Jr, Koonce T, Larson DM et al (1986) Palliation of small bowel obstruction by percutaneous gastrostomy in patients with progressive ovarian carcinoma. Obstet Gynecol 68:431\u20133","journal-title":"Obstet Gynecol"},{"key":"6889_CR61","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0009-9260(05)81270-X","volume":"44","author":"MJ Lee","year":"1991","unstructured":"Lee MJ, Saini S, Brink JA et al (1991) Malignant small bowel obstruction and ascites: not a contraindication to percutaneous gastrostomy. Clin Radiol 44:332\u20134","journal-title":"Clin Radiol"},{"key":"6889_CR62","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0016-5107(92)70423-4","volume":"38","author":"LL Herman","year":"1992","unstructured":"Herman LL, Hoskins WJ, Shike M (1992) Percutaneous endoscopic gastrostomy for decompression of the stomach and small bowel. Gastrointest Endosc 38:314\u20138","journal-title":"Gastrointest Endosc"},{"key":"6889_CR63","first-page":"467","volume":"81","author":"MD Adelson","year":"1993","unstructured":"Adelson MD, Kasowitz MH (1993) Percutaneous endoscopic drainage gastrostomy in the treatment of gastrointestinal obstruction from intraperitoneal malignancy. Obstet Gynecol 81:467\u201371","journal-title":"Obstet Gynecol"},{"key":"6889_CR64","first-page":"573","volume":"177","author":"WH Marks","year":"1993","unstructured":"Marks WH, Perkal MF, Schwartz PE (1993) Percutaneous endoscopic gastrostomy for gastric decompression in metastatic gynecologic malignancies. Surg Gynecol Obstet 177:573\u20136","journal-title":"Surg Gynecol Obstet"},{"key":"6889_CR65","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1055\/s-2007-1005700","volume":"27","author":"R Cannizzaro","year":"1995","unstructured":"Cannizzaro R, Bortoluzzi F, Valentini M et al (1995) Percutaneous endoscopic gastrostomy as a decompressive technique in bowel obstruction due to abdominal carcinomatosis. Endoscopy 27:317\u201320","journal-title":"Endoscopy"},{"key":"6889_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/gyno.1995.0021","volume":"59","author":"MJ Cunningham","year":"1995","unstructured":"Cunningham MJ, Bromberg C, Kredentser DC et al (1995) Percutaneous gastrostomy for decompression in patients with advanced gynecologic malignancies. Gynecol Oncol 59:273\u20136","journal-title":"Gynecol Oncol"},{"key":"6889_CR67","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1006\/gyno.1996.0197","volume":"62","author":"E Campagnutta","year":"1996","unstructured":"Campagnutta E, Cannizzaro R, Gallo A et al (1996) Palliative treatment of upper intestinal obstruction by gynecological malignancy: the usefulness of percutaneous endoscopic gastrostomy. Gynecol Oncol 62:103\u2013105","journal-title":"Gynecol Oncol"},{"key":"6889_CR68","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.2214\/ajr.171.4.9762985","volume":"171","author":"JM Ryan","year":"1998","unstructured":"Ryan JM, Hahn PF, Mueller PR (1998) Performing radiologic gastrostomy or gastrojejunostomy in patients with malignant ascites. AJR Am J Roentgenol 171:1003\u20136","journal-title":"AJR Am J Roentgenol"},{"key":"6889_CR69","doi-asserted-by":"crossref","unstructured":"Scheidbach H, Horbach T, Groitl H, et al. (1999) Percutaneous endoscopic gastrostomy\/jejunostomy (PEG\/PEJ) for decompression in the upper gastrointestinal tract. Initial experience with palliative treatment of gastrointestinal obstruction in terminally ill patients with advanced carcinomas. Surg Endosc 13:1103\u20131105","DOI":"10.1007\/s004649901182"},{"key":"6889_CR70","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1191\/0269216302pm590oa","volume":"16","author":"MA Brooksbank","year":"2002","unstructured":"Brooksbank MA, Game PA, Ashby MA (2002) Palliative venting gastrostomy in malignant intestinal obstruction. Palliat Med 16:520\u20136","journal-title":"Palliat Med"},{"key":"6889_CR71","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5737\/1181912x134212215","volume":"13","author":"L Jolicoeur","year":"2003","unstructured":"Jolicoeur L, Faught W (2003) Managing bowel obstruction in ovarian cancer using a percutaneous endoscopic gastrostomy (PEG) tube. Can Oncol Nurs J 13:212\u20139","journal-title":"Can Oncol Nurs J"},{"key":"6889_CR72","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00520-004-0749-4","volume":"13","author":"G Piccinni","year":"2005","unstructured":"Piccinni G, Angrisano A, Testini M et al (2005) Venting direct percutaneous jejunostomy (DPEJ) for drainage of malignant bowel obstruction in patients operated on for gastric cancer. Support Care Cancer 13:535\u20139","journal-title":"Support Care Cancer"},{"key":"6889_CR73","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ygyno.2004.09.058","volume":"96","author":"B Pothuri","year":"2005","unstructured":"Pothuri B, Montemarano M, Gerardi M et al (2005) Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma. Gynecol Oncol 96:330\u20134","journal-title":"Gynecol Oncol"},{"key":"6889_CR74","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jpainsymman.2010.05.007","volume":"41","author":"A Chakraborty","year":"2011","unstructured":"Chakraborty A, Selby D, Gardiner K et al (2011) Malignant bowel obstruction: natural history of a heterogeneous patient population followed prospectively over two years. J Pain Symptom Manage 41:412\u201320","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR75","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/MEG.0b013e32834b0e2a","volume":"23","author":"PG Vashi","year":"2011","unstructured":"Vashi PG, Dahlk S, Vashi RP et al (2011) Percutaneous endoscopic gastrostomy tube occlusion in malignant peritoneal carcinomatosis-induced bowel obstruction. Eur J Gastroenterol Hepatol 23:1069\u201373","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6889_CR76","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ygyno.2013.01.021","volume":"129","author":"KS Rath","year":"2013","unstructured":"Rath KS, Loseth D, Muscarella P et al (2013) Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer. Gynecol Oncol 129:103\u20136","journal-title":"Gynecol Oncol"},{"key":"6889_CR77","doi-asserted-by":"publisher","unstructured":"Teriaky A, Gregor J, Chande N (2012) Percutaneous endoscopic gastrostomy tube placement for end-stage palliation of malignant gastrointestinal obstructions.\u00a0Saudi J Gastroenterol. 18(2):95\u20138. https:\/\/doi.org\/10.4103\/1319-3767.93808","DOI":"10.4103\/1319-3767.93808"},{"key":"6889_CR78","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1245\/s10434-012-2643-5","volume":"20","author":"C Shaw","year":"2013","unstructured":"Shaw C, Bassett RL, Fox PS et al (2013) Palliative venting gastrostomy in patients with malignant bowel obstruction and ascites. Ann Surg Oncol 20:497\u2013505","journal-title":"Ann Surg Oncol"},{"key":"6889_CR79","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1007\/s00464-013-3368-7","volume":"28","author":"RB Issaka","year":"2014","unstructured":"Issaka RB, Shapiro DM, Parikh ND et al (2014) Palliative venting percutaneous endoscopic gastrostomy tube is safe and effective in patients with malignant obstruction. Surg Endosc 28:1668\u201373","journal-title":"Surg Endosc"},{"key":"6889_CR80","first-page":"208","volume":"26","author":"N Kawata","year":"2014","unstructured":"Kawata N, Kakushima N, Tanaka M et al (2014) Percutaneous endoscopic gastrostomy for decompression of malignant bowel obstruction. Dig 26:208\u201313","journal-title":"Dig"},{"key":"6889_CR81","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1089\/jpm.2014.0355","volume":"18","author":"TG DeEulis","year":"2015","unstructured":"DeEulis TG, Yennurajalingam S (2015) Venting gastrostomy at home for symptomatic management of bowel obstruction in advanced\/recurrent ovarian malignancy: a case series. J Palliat Med 18:722\u20138","journal-title":"J Palliat Med"},{"key":"6889_CR82","first-page":"2877","volume":"24","author":"E Zucchi","year":"2016","unstructured":"Zucchi E, Fornasarig M, Martella L et al (2016) Decompressive percutaneous endoscopic gastrostomy in advanced cancer patients with small-bowel obstruction is feasible and effective: a large prospective study. Support Care Cancer 24:2877\u201382","journal-title":"Support Care Cancer"},{"key":"6889_CR83","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s00520-017-3700-1","volume":"25","author":"A Dittrich","year":"2017","unstructured":"Dittrich A, Schubert B, Kramer M et al (2017) Benefits and risks of a percutaneous endoscopic gastrostomy (PEG) for decompression in patients with malignant gastrointestinal obstruction. Support Care Cancer 25:2849\u20132856","journal-title":"Support Care Cancer"},{"key":"6889_CR84","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bmjspcare-2019-001866","volume":"9","author":"R Singh Curry","year":"2019","unstructured":"Singh Curry R, Evans E, Raftery AM et al (2019) Percutaneous venting gastrostomy\/gastrojejunostomy for malignant bowel obstruction: a qualitative study. BMJ Support 9:381\u2013388","journal-title":"BMJ Support"},{"key":"6889_CR85","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1089\/jpm.2016.0465","volume":"20","author":"KA Pinard","year":"2017","unstructured":"Pinard KA, Goring TN, Egan BC et al (2017) Drainage percutaneous endoscopic gastrostomy for malignant bowel obstruction in gastrointestinal cancers: prognosis and implications for timing of palliative intervention. J Palliat Med 20:774\u2013778","journal-title":"J Palliat Med"},{"key":"6889_CR86","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/1756-0500-6-217","volume":"6","author":"Y Kurita","year":"2013","unstructured":"Kurita Y, Koide T, Watanabe S et al (2013) Postpyloric decompression tube placement through a gastrostomy for malignant bowel obstruction. BMC Res Notes 6:217","journal-title":"BMC Res Notes"},{"key":"6889_CR87","doi-asserted-by":"publisher","unstructured":"Gauvin G, Do-Nguyen CC, Lou J, et al. (2021) Gastrostomy tube for nutrition and malignant bowel obstruction in patients with cancer.\u00a0J Natl Compr Canc Netw 19(1):48\u201356. https:\/\/doi.org\/10.6004\/jnccn.2020.7604","DOI":"10.6004\/jnccn.2020.7604"},{"key":"6889_CR88","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s00520-019-05066-8","volume":"28","author":"T Aramaki","year":"2020","unstructured":"Aramaki T, Arai Y, Takeuchi Y et al (2020) A randomized, controlled trial of the efficacy of percutaneous transesophageal gastro-tubing (PTEG) as palliative care for patients with malignant bowel obstruction: the JIVROSG0805 trial. Support Care Cancer 28:2563\u20132569","journal-title":"Support Care Cancer"},{"key":"6889_CR89","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jvir.2013.04.005","volume":"24","author":"T Aramaki","year":"2013","unstructured":"Aramaki T, Arai Y, Inaba Y et al (2013) Phase II study of percutaneous transesophageal gastrotubing for patients with malignant gastrointestinal obstruction; JIVROSG-0205. J Vasc Interv Radiol 24:1011\u20137","journal-title":"J Vasc Interv Radiol"},{"key":"6889_CR90","doi-asserted-by":"crossref","unstructured":"Selby D, Nolen A, Sittambalam C, et al. (2019) Percutaneous transesophageal gastrostomy (PTEG): a safe and well-tolerated procedure for palliation of end-stage malignant bowel obstruction. J Pain Symptom Manage 58:306\u2013310","DOI":"10.1016\/j.jpainsymman.2019.04.031"},{"key":"6889_CR91","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jamcollsurg.2005.05.036","volume":"201","author":"R Mackey","year":"2005","unstructured":"Mackey R, Chand B, Oishi H et al (2005) Percutaneous transesophageal gastrostomy tube for decompression of malignant obstruction: report of the first case and our series in the US. J Am Coll Surg 201:695\u2013700","journal-title":"J Am Coll Surg"},{"key":"6889_CR92","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.amsu.2015.07.018","volume":"4","author":"HJ Ferguson","year":"2015","unstructured":"Ferguson HJ, Ferguson CI, Speakman J et al (2015) Management of intestinal obstruction in advanced malignancy. Ann Med Surg (Lond) 4:264\u201370","journal-title":"Ann Med Surg (Lond)"},{"key":"6889_CR93","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/jamasurg.2013.4059","volume":"149","author":"TJ Paul Olson","year":"2014","unstructured":"Paul Olson TJ, Pinkerton C, Brasel KJ et al (2014) Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review. JAMA Surg 149:383\u201392","journal-title":"JAMA Surg"},{"key":"6889_CR94","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11938-005-0015-y","volume":"8","author":"DG Adler","year":"2005","unstructured":"Adler DG (2005) Management of malignant colonic obstruction. Curr Treat Options Gastroenterol 8:231\u2013237","journal-title":"Curr Treat Options Gastroenterol"},{"key":"6889_CR95","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.gie.2014.09.018","volume":"80","author":"JE Van Hooft","year":"2014","unstructured":"Van Hooft JE, Van Halsema EE, Vanbiervliet G et al (2014) Self-expandable metal stents for obstructing colonic and extracolonic cancer: European society of gastrointestinal endoscopy (ESGE) Clinical Guideline. Gastrointest Endosc 80:747-761.e7","journal-title":"Gastrointest Endosc"},{"key":"6889_CR96","doi-asserted-by":"crossref","unstructured":"Wang FG, Bai RX, Yan M, et al. (2020) Short-term outcomes of self-expandable metallic stent versus decompression tube for malignant colorectal obstruction: a meta-analysis of clinical data. J Investig Surg 33:762\u2013770","DOI":"10.1080\/08941939.2019.1566419"},{"key":"6889_CR97","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11605-015-2997-7","volume":"20","author":"YN Atukorale","year":"2016","unstructured":"Atukorale YN, Church JL, Hoggan BL et al (2016) Self-expanding metallic stents for the management of emergency malignant large bowel obstruction: a systematic review. J Gastrointest Surg 20:455\u201362","journal-title":"J Gastrointest Surg"},{"key":"6889_CR98","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00384-012-1599-z","volume":"28","author":"V Cennamo","year":"2013","unstructured":"Cennamo V, Luigiano C, Coccolini F et al (2013) Meta-analysis of randomized trials comparing endoscopic stenting and surgical decompression for colorectal cancer obstruction. Int J Color Dis 28:855\u2013863","journal-title":"Int J Color Dis"},{"key":"6889_CR99","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s10151-020-02296-5","volume":"24","author":"SR Jain","year":"2020","unstructured":"Jain SR, Yaow CYL, Ng CH et al (2020) Comparison of colonic stents, stomas and resection for obstructive left colon cancer: a meta-analysis. Tech Coloproctol 24:1121\u20131136","journal-title":"Tech Coloproctol"},{"key":"6889_CR100","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1046\/j.1365-2168.2002.02148.x","volume":"89","author":"UP Khot","year":"2002","unstructured":"Khot UP, Lang AW, Murali K et al (2002) Systematic review of the efficacy and safety of colorectal stents. Br J Surg 89:1096\u2013102","journal-title":"Br J Surg"},{"key":"6889_CR101","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00384-021-03834-9","volume":"36","author":"VSQ Neo","year":"2021","unstructured":"Neo VSQ, Jain SR, Yeo JW et al (2021) Controversies of colonic stenting in obstructive left colorectal cancer: a critical analysis with meta-analysis and meta-regression. Int J Colorectal Dis 36:689\u2013700","journal-title":"Int J Colorectal Dis"},{"key":"6889_CR102","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/01.sla.0000261124.72687.72","volume":"246","author":"AM Watt","year":"2007","unstructured":"Watt AM, Faragher IG, Griffin TT et al (2007) Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review. Ann Surg 246:24\u201330","journal-title":"Ann Surg"},{"key":"6889_CR103","doi-asserted-by":"publisher","unstructured":"Veld J, Umans D, van Halsema E, et al. (2020) Self-expandable metal stent (SEMS) placement or emergency surgery as palliative treatment for obstructive colorectal cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol 155:103110. https:\/\/doi.org\/10.1016\/j.critrevonc.2020.103110","DOI":"10.1016\/j.critrevonc.2020.103110"},{"key":"6889_CR104","doi-asserted-by":"publisher","first-page":"E558","DOI":"10.1055\/a-0591-2883","volume":"6","author":"IB Ribeiro","year":"2018","unstructured":"Ribeiro IB, Bernardo WM, Martins BDC et al (2018) Colonic stent versus emergency surgery as treatment of malignant colonic obstruction in the palliative setting: a systematic review and meta-analysis. Endosc Int Open 6:E558\u2013E567","journal-title":"Endosc Int Open"},{"key":"6889_CR105","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/codi.13951","volume":"20","author":"CJ Young","year":"2018","unstructured":"Young CJ, Zahid A (2018) Randomized controlled trial of colonic stent insertion in non-curable large bowel obstruction: a post hoc cost analysis. Colorectal Dis 20:288\u2013295","journal-title":"Colorectal Dis"},{"key":"6889_CR106","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/ans.16188","volume":"91","author":"SP Banting","year":"2021","unstructured":"Banting SP, Waters PS, Peacock O et al (2021) Management of primary and metastatic malignant small bowel obstruction, operate or palliate. A systematic review. ANZ J Surg 91:282\u2013290","journal-title":"ANZ J Surg"},{"key":"6889_CR107","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/0002-9610(86)90155-8","volume":"152","author":"B Gemlo","year":"1986","unstructured":"Gemlo B, Rayner AA, Lewis B et al (1986) Home support of patients with end-stage malignant bowel obstruction using hydration and venting gastrostomy. Am J Surg 152:100\u20134","journal-title":"Am J Surg"},{"key":"6889_CR108","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1007\/s00520-019-04948-1","volume":"27","author":"F Bozzetti","year":"2019","unstructured":"Bozzetti F (2019) The role of parenteral nutrition in patients with malignant bowel obstruction. Support Care Cancer 27:4393\u20134399","journal-title":"Support Care Cancer"},{"key":"6889_CR109","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","volume":"40","author":"M Muscaritoli","year":"2021","unstructured":"Muscaritoli M, Arends J, Bachmann P et al (2021) ESPEN practical guideline: clinical nutrition in cancer. Clin Nutr 40:2898\u20132913","journal-title":"Clin Nutr"},{"key":"6889_CR110","unstructured":"NHS Scotland (2020) Scottish palliative care guidelines. Bowel Obstruction. https:\/\/www.palliativecareguidelines.scot.nhs.uk\/guidelines\/symptom-control\/bowel-obstruction.aspx Accessed on: 15th July 2021"},{"key":"6889_CR111","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.clnu.2016.02.006","volume":"35","author":"C Druml","year":"2016","unstructured":"Druml C, Ballmer PE, Druml W et al (2016) ESPEN guideline on ethical aspects of artificial nutrition and hydration. Clin Nutr 35:545\u201356","journal-title":"Clin Nutr"},{"key":"6889_CR112","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3945\/an.115.009688","volume":"6","author":"E Vanhauwaert","year":"2015","unstructured":"Vanhauwaert E, Matthys C, Verdonck L et al (2015) Low-residue and low-fiber diets in gastrointestinal disease management. Adv Nutr 6:820\u20137","journal-title":"Adv Nutr"},{"key":"6889_CR113","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00520-014-2591-7","volume":"23","author":"F Bozzetti","year":"2015","unstructured":"Bozzetti F (2015) Nutrition, hydration, and patient\u2019s preferences at the end of life. Support Care Cancer 23:1487\u20138","journal-title":"Support Care Cancer"},{"key":"6889_CR114","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/1049909119897401","volume":"37","author":"TA Coelho","year":"2020","unstructured":"Coelho TA, Wainstein AJA, Drummond-Lage AP (2020) Hypodermoclysis as a strategy for patients with end-of-life cancer in home care settings. Am J Hosp Palliat Care 37:675\u2013682","journal-title":"Am J Hosp Palliat Care"},{"key":"6889_CR115","doi-asserted-by":"publisher","unstructured":"Good P, Richard R, Syrmis W, et al. (2014) Medically assisted hydration for adult palliative care patients. Cochrane Database Syst Rev\u00a023;(4):CD006273. https:\/\/doi.org\/10.1002\/14651858.CD006273","DOI":"10.1002\/14651858.CD006273"},{"key":"6889_CR116","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/bmjspcare-2018-001729","volume":"11","author":"ME Lokker","year":"2021","unstructured":"Lokker ME, van der Heide A, Oldenmenger WH et al (2021) Hydration and symptoms in the last days of life. BMJ Support Palliat Care 11:335\u2013343","journal-title":"BMJ Support Palliat Care"},{"key":"6889_CR117","doi-asserted-by":"crossref","unstructured":"Raijmakers NJH, van Zuylen L, Costantini M, et al. (2011) Artificial nutrition and hydration in the last week of life in cancer patients. A systematic literature review of practices and effects. Ann Oncol 22:1478\u20131486","DOI":"10.1093\/annonc\/mdq620"},{"key":"6889_CR118","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1200\/JCO.2012.44.6518","volume":"31","author":"E Bruera","year":"2013","unstructured":"Bruera E, Hui D, Dalal S et al (2013) Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol 31:111\u20138","journal-title":"J Clin Oncol"},{"key":"6889_CR119","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.clnu.2012.08.004","volume":"32","author":"M Dreesen","year":"2013","unstructured":"Dreesen M, Foulon V, Spriet I et al (2013) Epidemiology of catheter-related infections in adult patients receiving home parenteral nutrition: a systematic review. Clin Nutr 32:16\u201326","journal-title":"Clin Nutr"},{"key":"6889_CR120","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.clnu.2009.03.015","volume":"28","author":"M Pittiruti","year":"2009","unstructured":"Pittiruti M, Hamilton H, Biffi R et al (2009) ESPEN guidelines on parenteral nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr 28:365\u201377","journal-title":"Clin Nutr"},{"key":"6889_CR121","doi-asserted-by":"crossref","unstructured":"Sowerbutts AM, Lal S, Sremanakova J, et al. (2018) Home parenteral nutrition for people with inoperable malignant bowel obstruction. Cochrane Database Syst Rev 8:CD012812","DOI":"10.1002\/14651858.CD012812.pub2"},{"key":"6889_CR122","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1054\/clnu.2002.0560","volume":"21","author":"F Bozzetti","year":"2002","unstructured":"Bozzetti F, Cozzaglio L, Biganzoli E et al (2002) Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr 21:281\u20138","journal-title":"Clin Nutr"},{"key":"6889_CR123","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1002\/cam4.1111","volume":"6","author":"P Cotogni","year":"2017","unstructured":"Cotogni P, De Carli L, Passera R et al (2017) Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Med 6:1799\u20131806","journal-title":"Cancer Med"},{"key":"6889_CR124","first-page":"98","volume":"20","author":"C Finocchiaro","year":"2002","unstructured":"Finocchiaro C, Gervasio S, Agnello E et al (2002) Multicentric study on home parenteral nutrition in advanced cancer patients. Riv Ital Nutrizione Parenterale Enterale 20:98\u2013107","journal-title":"Riv Ital Nutrizione Parenterale Enterale"},{"key":"6889_CR125","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.clnu.2014.09.010","volume":"34","author":"M Naghibi","year":"2015","unstructured":"Naghibi M, Smith TR, Elia M (2015) A systematic review with meta-analysis of survival, quality of life and cost-effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction. Clin Nutr 34:825\u201337","journal-title":"Clin Nutr"},{"key":"6889_CR126","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1093\/annonc\/mdv365","volume":"26","author":"F Bozzetti","year":"2015","unstructured":"Bozzetti F, Cotogni P, Lo Vullo S et al (2015) Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition. Ann Oncol 26:2335\u201340","journal-title":"Ann Oncol"},{"key":"6889_CR127","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/0016-5085(95)90196-5","volume":"108","author":"B Messing","year":"1995","unstructured":"Messing B, L\u00e9mann M, Landais P et al (1995) Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology 108:1005\u201310","journal-title":"Gastroenterology"},{"key":"6889_CR128","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1016\/j.clnu.2020.02.021","volume":"39","author":"E Ruggeri","year":"2020","unstructured":"Ruggeri E, Giannantonio M, Agostini F et al (2020) Home artificial nutrition in palliative care cancer patients: Impact on survival and performance status. Clin Nutr 39:3346\u20133353","journal-title":"Clin Nutr"},{"key":"6889_CR129","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ygyno.2006.02.013","volume":"103","author":"L Brard","year":"2006","unstructured":"Brard L, Weitzen S, Strubel-Lagan SL et al (2006) The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients. Gynecol Oncol 103:176\u201380","journal-title":"Gynecol Oncol"},{"key":"6889_CR130","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/cam4.587","volume":"5","author":"J Chouhan","year":"2016","unstructured":"Chouhan J, Gupta R, Ensor J et al (2016) Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction. Cancer Med 5:239\u201347","journal-title":"Cancer Med"},{"key":"6889_CR131","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.nut.2005.06.011","volume":"22","author":"L Santarpia","year":"2006","unstructured":"Santarpia L, Alfonsi L, Pasanisi F et al (2006) Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition 22:355\u201360","journal-title":"Nutrition"},{"key":"6889_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu13030889","volume":"13","author":"T Dzierzanowski","year":"2021","unstructured":"Dzierzanowski T, Sobocki J (2021) Survival of patients with multi-level malignant bowel obstruction on total parenteral nutrition at home. Nutrients 13:1\u201312","journal-title":"Nutrients"},{"key":"6889_CR133","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jamaoncol.2019.0086","volume":"5","author":"V Jairam","year":"2019","unstructured":"Jairam V, Lee V, Park HS et al (2019) Treatment-related complications of systemic therapy and radiotherapy. JAMA Oncol 5:1028\u20131035","journal-title":"JAMA Oncol"},{"key":"6889_CR134","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3348\/kjr.2014.15.4.494","volume":"15","author":"J Shim","year":"2014","unstructured":"Shim J, Seo TS, Song MG et al (2014) Incidence and risk factors of infectious complications related to implantable venous-access ports. Korean J Radiol 15:494\u2013500","journal-title":"Korean J Radiol"},{"key":"6889_CR135","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1186\/s12885-019-6181-4","volume":"19","author":"CL Niedzwiedz","year":"2019","unstructured":"Niedzwiedz CL, Knifton L, Robb KA et al (2019) Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer 19:943","journal-title":"BMC Cancer"},{"key":"6889_CR136","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/pon.3409","volume":"23","author":"AM Krebber","year":"2014","unstructured":"Krebber AM, Buffart LM, Kleijn G et al (2014) Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology 23:121\u201330","journal-title":"Psychooncology"},{"key":"6889_CR137","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.clnu.2016.12.003","volume":"36","author":"P Caillet","year":"2017","unstructured":"Caillet P, Liuu E, Raynaud Simon A et al (2017) Association between cachexia, chemotherapy and outcomes in older cancer patients: a systematic review. Clin Nutr 36:1473\u20131482","journal-title":"Clin Nutr"},{"key":"6889_CR138","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.2147\/CMAR.S261585","volume":"12","author":"J Ni","year":"2020","unstructured":"Ni J, Zhang L (2020) Cancer Cachexia: Definition, staging, and emerging treatments. Cancer Manag Res 12:5597\u20135605","journal-title":"Cancer Manag Res"},{"key":"6889_CR139","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0885-3924(94)00076-W","volume":"10","author":"ML Vachon","year":"1995","unstructured":"Vachon ML, Kristjanson L, Higginson I (1995) Psychosocial issues in palliative care: the patient, the family, and the process and outcome of care. J Pain Symptom Manage 10:142\u201350","journal-title":"J Pain Symptom Manage"},{"key":"6889_CR140","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1017\/S1478951519000592","volume":"18","author":"ML M\u00f6llerberg","year":"2020","unstructured":"M\u00f6llerberg ML, \u00c5restedt K, Sandgren A et al (2020) Adaptation and psychometric evaluation of the short version of family sense of coherence scale in a sample of persons with cancer in the palliative stage and their family members. Palliat Support Care 18:24\u201332","journal-title":"Palliat Support Care"},{"key":"6889_CR141","doi-asserted-by":"publisher","first-page":"593","DOI":"10.12968\/ijpn.2013.19.12.593","volume":"19","author":"P Daines","year":"2013","unstructured":"Daines P, Stilos K, Moura S et al (2013) Nurses\u2019 experiences caring for patients and families dealing with malignant bowel obstruction. Int J Palliat Nurs 19:593\u20138","journal-title":"Int J Palliat Nurs"},{"key":"6889_CR142","doi-asserted-by":"publisher","first-page":"547","DOI":"10.12968\/ijpn.2001.7.11.9295","volume":"7","author":"V Platt","year":"2001","unstructured":"Platt V (2001) Malignant bowel obstruction: so much more than symptom control. Int J Palliat Nurs 7:547\u201354","journal-title":"Int J Palliat Nurs"},{"key":"6889_CR143","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1586\/14737140.8.2.227","volume":"8","author":"DM Chase","year":"2008","unstructured":"Chase DM, Monk BJ, Wenzel LB et al (2008) Supportive care for women with gynecologic cancers. Expert Rev Anticancer Ther 8:227\u201341","journal-title":"Expert Rev Anticancer Ther"},{"key":"6889_CR144","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ygyno.2020.03.009","volume":"157","author":"MC Cusimano","year":"2020","unstructured":"Cusimano MC, Sajewycz K, Nelson M et al (2020) Supported self-management as a model for end-of-life care in the setting of malignant bowel obstruction: a qualitative study. Gynecol Oncol 157:745\u2013753","journal-title":"Gynecol Oncol"},{"key":"6889_CR145","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1200\/JOP.19.00710","volume":"16","author":"C Hoppenot","year":"2020","unstructured":"Hoppenot C, Hlubocky FJ, Chor J et al (2020) Approach to palliative care consultation for patients with malignant bowel obstruction in gynecologic oncology: a qualitative analysis of physician perspectives. JCO Oncol Pract 16:483\u2013489","journal-title":"JCO Oncol Pract"},{"key":"6889_CR146","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1177\/0003134820973028","volume":"86","author":"EA Fallon","year":"2020","unstructured":"Fallon EA, Miner TJ (2020) Malignant bowel obstruction in the time of the COVID-19 pandemic. Am Surg 86:1473\u20131477","journal-title":"Am Surg"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06889-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-06889-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06889-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T22:20:43Z","timestamp":1726784443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-06889-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":146,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6889"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-06889-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1077646\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"assertion":[{"value":"15 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study did not directly involve any human subjects and, therefore, consent was not applicable for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}